Clinical Trials Logo

Clinical Trial Summary

This study is designed as a randomised multicentric parallel group pragmatic trial of Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) versus Descemet Membrane Endothelial Keratoplasty (DMEK) in corneal endothelial decompensation. the purpose is to compare the clinical and patient reported outcomes of both therapies across a broad range of indications.


Clinical Trial Description

The current problem concerns variability in the provision of corneal endothelial keratoplasties available to patients in Belgium. Some patients receive DSAEK and some (albeit fewer) receive DMEK. Currently the type of corneal graft that a patient receives depends on the treating surgeon opinions. In this study 220 patients in 11 surgical centres will be recruited and allocated to one of the two surgical options. Both the Ultrathin DSAEK and DMEK grafts will be prepared by corneal banks in the University Hospital of Liege and University Hospital of Antwerp respectively. Patients will be examined preoperatively and postoperatively at 3, 6 and 12 months. Clinical information such as best-corrected visual acuity and refraction will be collected as well as quality of life information based on the EQ-5D-5L and the VFQ 25 assessment tools. These data be used to compare the interventions both on the clinical level as well as from the patient perspective. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05436665
Study type Interventional
Source University Hospital, Antwerp
Contact Veerle Van Gerwen, BSc
Phone +3238210000
Email bestcornea@uza.be
Status Recruiting
Phase N/A
Start date August 10, 2022
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT03248037 - Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation Phase 3
Recruiting NCT03275896 - Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy Early Phase 1
Completed NCT02332109 - ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy N/A
Completed NCT02470793 - Technique And Results In Endothelial Keratoplasty N/A
Recruiting NCT01206127 - DSAEK- Postoperative Positioning and Transplant Dislocation N/A
Recruiting NCT03407755 - Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK) N/A
Completed NCT04140422 - Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea N/A
Recruiting NCT06048380 - The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery Phase 3
Completed NCT02793310 - DMEK Versus DSAEK Study N/A
Completed NCT01795001 - The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
Completed NCT04057053 - Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty Early Phase 1
Terminated NCT01361282 - Using the Optovue OCT to Select IOL Power N/A
Completed NCT02542644 - Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT N/A
Recruiting NCT04191629 - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema Phase 1
Completed NCT05399095 - Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty N/A
Not yet recruiting NCT06261346 - Plasma Rich in Growth Factors in Corneal Endothelial Transplantation N/A
Completed NCT04752020 - Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty Early Phase 1
Not yet recruiting NCT05716945 - The OPTIMISE Study Phase 4
Recruiting NCT03575130 - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy Phase 2
Recruiting NCT02118922 - A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia